Author page: Kathrin Folkendt

Autoimmune Benefits: The Next Big Thing in Workplace Health Initiatives?

The evolution of workplace health benefits is a testament to the growing awareness and sensitivity towards diverse employee needs. From mental health support to fertility and menopause benefits, employers have increasingly embraced a holistic approach to employee well-being over the past years. Now, with the recent announcement from WellTheory and Maven Clinic, there’s a compelling case that autoimmune benefits might just be…

Serac Healthcare Presents Novel Imaging Approach for Endometriosis Diagnosis at SRI Annual Meeting

Serac Healthcare, a clinical radiopharmaceutical company, has made a significant stride in the diagnosis of endometriosis. The company has announced the preliminary results from the first patient cohort in the “Detecting Endometriosis expressed integrins using technetium-99m” (DETECT) study, focusing on the imaging of endometriosis using the innovative agent 99mTc-maraciclatide. These findings are set to be presented at the Society for Reproductive Investigation…

Fertilis’ MicroICSI Is Set to Enhance IVF Outcomes According to New Study

Fertilis, an Australian medtech company, has developed the prototype of an innovative device, microICSI, aimed at refining the IVF process. A recent study published in the Journal of Assisted Reproduction and Genetics study, titled “A micro-fabricated device (microICSI) improves porcine blastocyst development and procedural efficiency for both porcine intracytoplasmic sperm injection and human microinjection,” now underscores the device’s effectiveness in improving embryo…

Cross-Border Impact Ventures Exceeds $90M in Final Close of Inaugural Fund Dedicated to Women’s and Children’s Health

Cross-Border Impact Ventures (CBIV) has recently announced the successful closing of its Women’s and Children’s Health Technology Fund, raising over $90 million in investor commitments. The fund is dedicated to investing in technology companies that address the health needs of women, children, and adolescents, and also aims to enhance the resilience of health systems. Based in North America and Europe, CBIV targets…

The Femtech Word of the Year: Momentum

Last week, we finally got together for this year’s “Femtech Trends & Opportunities” webinar. A big thank you to everyone who joined us live. If you missed it, don’t fret: Today’s newsletter will catch you up on everything you need to know about women’s health innovation in 2024 and we’ll also share the recording to make sure you’re in the loop as you start into the…

Vyld Secures Seven-Figure Funding for Seaweed-based Women’s Health Products Using Novel Financing Model

Vyld, a Berlin-based profit-for-purpose company, has successfully completed a significant seed funding round, securing a seven-figure sum to advance its mission of developing sustainable, ocean-friendly products. The funding round, backed by a blend of government funds, the EU, and a cohort of angel investors and venture funds, reflects a growing interest in sustainable innovations in the women’s health sector. Founded by Ines…

Compass Diversified Partners with The Honey Pot Company in $380M Deal to Expand Feminine Care Offerings

Compass Diversified (CODI), known for its portfolio of leading middle-market businesses, has entered into a partnership with The Honey Pot Company, a brand specializing in “better-for-you” feminine care products. The agreement, which carries an enterprise value of $380 million, aims to reinforce The Honey Pot Company’s commitment to providing comprehensive and holistic feminine care systems. Originating from a personal need for healthier…

Oura Ring & Natural Cycles for Birth Control or Fertility Tracking: Everything You Need to Know! (2024 Review)

Initially the Oura Ring promised better sleep, but its collaboration with Natural Cycles delivered something I hadn’t envisioned: a smart, straightforward way to manage my reproductive health. Starting in August 2022, I began using an Oura Ring alongside Natural Cycles initially for contraception. This partnership has transformed my approach to fertility and contraception, evolving from a background concern into an integrated part…